| Literature DB >> 33083048 |
Jasmine Y Serpen1,2, Lev Prasov1,3,4, Wadih M Zein1, Catherine A Cukras1, Denise Cunningham1, Elizabeth C Murphy1, Amy Turriff1,5, Brian P Brooks1, Laryssa A Huryn1.
Abstract
MATERIALS AND METHODS: Electronic medical records of patients evaluated in the Ophthalmic Genetics clinic at the National Eye Institute (NEI) between 2008 and 2018 were searched for a superficial ODD diagnosis. Color fundus and autofluorescence images were reviewed to confirm ODD, supplemented with optical coherence tomography (OCT) in uncertain cases when available. Demographic information, examination, and genetic testing were reviewed. Disc areas and disc-to-macula distance to disc diameter ratios (DM : DD) were calculated.Entities:
Year: 2020 PMID: 33083048 PMCID: PMC7557906 DOI: 10.1155/2020/5082706
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1Flowchart depicting electronic medical record queries and validation.
Figure 2Optic disc parameters among the inherited retinal degeneration cohort. (a) Schematic diagram of optic disc parameters; black “x” indicates fovea centralis, taken as the macula, the navy line represents temporal edge of disc-to-macula distance, the white line indicates horizontal disc diameter, the magenta line indicates vertical disc diameter, and green circumference highlights optic disc area. Disc-to-macula distance (DM) was defined as the distance from the center of the disc to the macula, and disc diameter (DD) was defined as the average of the horizontal and vertical disc diameter. (b) Color fundus image of a patient with optic disc drusen (ODD) and retinitis pigmentosa, with measurements corresponding to schematic diagram in (a). (c) Fundus autofluorescence of the same patient with ODD and retinitis pigmentosa. Drusen are visualized as hyperautofluorescent areas on the optic disc. Box plots of (d) optic disc area and (e) DM : DD among each cohort and subgroup, with each individual data point representing one scored image. Patients with ODD and Usher syndrome had significantly smaller disc area and DM : DD than patients with ODD without Usher syndrome. P < 0.05.
ODD cohort diagnoses.
| Diagnosis | Number of ODD patients (%) |
|---|---|
| Retinal degeneration | 42 (75) |
| Rod-cone dystrophy | 36 (64) |
| Macular and/or cone-predominant dystrophy | 6 (11) |
| Genetic condition without a retinal degeneration | 14 (25) |
|
| |
| Isolated ocular condition | 28 (50) |
| Syndromic ocular condition | 21 (38) |
| Genetic conditions for which ophthalmic evaluations were requested | 7 (12) |
Demographic and ophthalmic characteristics of ODD and control patients.
| ODD—all ( | ODD—unilateral ( | ODD—bilateral ( | Control ( | |
|---|---|---|---|---|
| Sex | ||||
| Male | 21 (38%) | 7 (37%) | 14 (38%) | 30 (54%) |
| Female | 35 (62%) | 12 (63%) | 23 (62%) | 26 (46%) |
|
| ||||
| Age (mean ± SD, years) | 32.9 ± 17.5 | 30.7 ± 18.5 | 34.1 ± 17.1 | 38.6 ± 17.8 |
|
| ||||
| Age (range, years) | 5.0–73.0 | 5.0–69.0 | 8.0–73.0 | 3.0–84.0 |
|
| ||||
| Race | ||||
| Caucasian | 41 (73%) | 14 (74%) | 27 (73%) | 28 (50%) |
| AA | 2 (4%) | 1 (5%) | 1 (3%) | 15 (27%) |
| Others | 13 (23%) | 4 (21%) | 9 (24%) | 13 (23%) |
|
| ||||
| LogMAR BCVA (range) | ||||
| OD | −0.097-LP | 0.000–1.204 | −0.097-LP | −0.097-LP |
| OS | −0.097-NLP | 0.000-CF | −0.097-NLP | −0.204-LP |
|
| ||||
| Refractive error (median, IQR, D) | ||||
| OD | −1.00 (2.88) | −1.63 (2.16) | −0.38 (2.38) | −1.63 (3.88) |
| OS | −0.63 (3.50) | −1.88 (4.25) | −0.25 (3.00) | −1.38 (3.53) |
SD: standard deviation; AA: African American; logMAR BCVA: logarithm of the minimal angle of resolution best-corrected visual acuity; OD: right eye; OS: left eye; LP: light perception; NLP: no light perception; CF: count fingers; IQR: interquartile range; D: diopter.
Usher cohort genetic testing results.
| Usher gene | Number of patients ( | Number of ODD patients ( |
|---|---|---|
|
| 55 (42) | 2 (4) |
|
| 17 (13) | 2 (4) |
|
| 10 (8) | 3 (5) |
|
| 8 (6) | 1 (2) |
|
| 7 (5) | 0 |
|
| 6 (5) | 1 (2) |
|
| 5 (4) | 0 |
|
| 2 (2) | 0 |
| Multiple genes | 6 (5) | 0 |
| Clinical phenotype | 16 (12) | 1 (2) |